Lexaria Bioscience Corp. Common Stock (LEXX)
Stock · NASDAQ · Health Care
$10.35as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
About LEXX
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved t…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 7
- Website
- lexariabioscience.com
Fundamentals
- 1-day range
- $10.24$11.68
- Market cap
- $117.74M
- P/E (trailing)
- —
- P/E (forward)
- -29.95
- EPS (trailing)
- $-5.10
- Dividend yield
- —
- Beta
- 0.37
- Avg. volume
- 15.6K
- Dividend pay date
- January 12, 2021
How Lexaria Bioscience Corp. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Nov 28, 2025 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
Lexaria Bioscience Corp. Common Stock Competitors
Chosen by industry and closest market cap.
- LEXXLexaria Bioscience Corp. Common Stock$10.35▼ 11.39%Market cap $117.74MP/E —$4.21$23.25
- SPRBSpruce Biosciences Inc. Common Stock$60.05▼ 5.13%Market cap $118.73MP/E —$7$240
- BGMBGM Group Ltd. Class A Ordinary Shares$0.3251▲ 11.34%Market cap $116.58MP/E —$0.2287$11.8
- CNTBConnect Biopharma Holdings Limited Ordinary Shares$2.22▼ 2.63%Market cap $124.04MP/E —$1.23$3.82
- IFRXInflaRx N.V. Common Stock$2.22▼ 2.20%Market cap $126.51MP/E —$0.7984$2.95
- PMNProMIS Neurosciences Inc. Common Shares (ON)$13.79▼ 1.43%Market cap $126.80MP/E —$6.27$27.4
- VTVTvTv Therapeutics Inc. Class A Common Stock$32.17▼ 1.92%Market cap $127.58MP/E 55.59$15.79$44
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| LEXX Lexaria Bioscience Corp. Common Stock | $117.74M | — | $10.35 | ▼ 11.39% | $4.21$23.25 |
| SPRB Spruce Biosciences Inc. Common Stock | $118.73M | — | $60.05 | ▼ 5.13% | $7$240 |
| BGM BGM Group Ltd. Class A Ordinary Shares | $116.58M | — | $0.3251 | ▲ 11.34% | $0.2287$11.8 |
| CNTB Connect Biopharma Holdings Limited Ordinary Shares | $124.04M | — | $2.22 | ▼ 2.63% | $1.23$3.82 |
| IFRX InflaRx N.V. Common Stock | $126.51M | — | $2.22 | ▼ 2.20% | $0.7984$2.95 |
| PMN ProMIS Neurosciences Inc. Common Shares (ON) | $126.80M | — | $13.79 | ▼ 1.43% | $6.27$27.4 |
| VTVT vTv Therapeutics Inc. Class A Common Stock | $127.58M | 55.59 | $32.17 | ▼ 1.92% | $15.79$44 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.